Sudha Desai

544 total citations
15 papers, 304 citations indexed

About

Sudha Desai is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Sudha Desai has authored 15 papers receiving a total of 304 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Immunology. Recurrent topics in Sudha Desai's work include PARP inhibition in cancer therapy (5 papers), BRCA gene mutations in cancer (3 papers) and Immune Response and Inflammation (3 papers). Sudha Desai is often cited by papers focused on PARP inhibition in cancer therapy (5 papers), BRCA gene mutations in cancer (3 papers) and Immune Response and Inflammation (3 papers). Sudha Desai collaborates with scholars based in United Kingdom, United States and Germany. Sudha Desai's co-authors include Robert D. Morgan, Louisa Nelson, Joanne C. McGrail, Anthony Tighe, George J. Burghel, Stephen S. Taylor, I‐Hsuan Lin, Kelli R. Ryan, Susan Lukas and Louise K. Modis and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and The FASEB Journal.

In The Last Decade

Sudha Desai

15 papers receiving 303 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sudha Desai United Kingdom	9	148	88	58	56	33	15	304
Martin Hellriegel Germany	8	227 1.5×	104 1.2×	30 0.5×	29 0.5×	20 0.6×	15	372
Rashi Kalra India	12	146 1.0×	76 0.9×	21 0.4×	117 2.1×	39 1.2×	24	379
Malavika Ghosh United States	5	178 1.2×	177 2.0×	34 0.6×	141 2.5×	16 0.5×	5	427
Laura Devis Spain	8	229 1.5×	76 0.9×	53 0.9×	55 1.0×	21 0.6×	11	408
J. Milliken Australia	10	105 0.7×	151 1.7×	34 0.6×	44 0.8×	67 2.0×	14	379
G. Spatti Italy	6	126 0.9×	219 2.5×	100 1.7×	12 0.2×	64 1.9×	7	358
Dongyi Wan China	10	326 2.2×	153 1.7×	29 0.5×	37 0.7×	33 1.0×	16	481
Yanling Fan China	9	249 1.7×	130 1.5×	9 0.2×	50 0.9×	26 0.8×	11	384
Carmen E. Pyragius Australia	10	248 1.7×	84 1.0×	40 0.7×	54 1.0×	12 0.4×	10	393
Michał Świerniak Poland	12	393 2.7×	69 0.8×	22 0.4×	45 0.8×	42 1.3×	19	627

Countries citing papers authored by Sudha Desai

Since Specialization

Citations

This map shows the geographic impact of Sudha Desai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sudha Desai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sudha Desai more than expected).

Fields of papers citing papers by Sudha Desai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sudha Desai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sudha Desai. The network helps show where Sudha Desai may publish in the future.

Co-authorship network of co-authors of Sudha Desai

This figure shows the co-authorship network connecting the top 25 collaborators of Sudha Desai. A scholar is included among the top collaborators of Sudha Desai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sudha Desai. Sudha Desai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Morgan, Robert D., Xin Wang, Jurjees Hasan, et al.. (2024). Germline BRCA1/2 status and chemotherapy response score in high-grade serous ovarian cancer. British Journal of Cancer. 131(12). 1919–1927. 5 indexed citations

Nelson, Louisa, Anthony Tighe, Samantha Littler, et al.. (2023). Exploiting a living biobank to delineate mechanisms underlying disease-specific chromosome instability. Chromosome Research. 31(3). 21–21. 5 indexed citations

Morgan, Robert D., George J. Burghel, Hélene Schlecht, et al.. (2023). Real-World Concordance between Germline and Tumour BRCA1/2 Status in Epithelial Ovarian Cancer. Cancers. 16(1). 177–177. 2 indexed citations

Morgan, Robert D., George J. Burghel, Michael Bulman, et al.. (2022). Predicting the likelihood of a BRCA1/2 pathogenic variant being somatic by testing only tumour DNA in non-mucinous high-grade epithelial ovarian cancer. Journal of Clinical Pathology. 76(10). 684–689. 3 indexed citations

Morgan, Robert D., Louisa Nelson, Anthony Tighe, et al.. (2021). Replication catastrophe is responsible for intrinsic PAR glycohydrolase inhibitor-sensitivity in patient-derived ovarian cancer models. Journal of Experimental & Clinical Cancer Research. 40(1). 323–323. 26 indexed citations

Nelson, Louisa, Anthony Tighe, George J. Burghel, et al.. (2021). Distinct transcriptional programs stratify ovarian cancer cell lines into the five major histological subtypes. Genome Medicine. 13(1). 140–140. 77 indexed citations

Dorpe, Jo Van, Joni Van der Meulen, Sudha Desai, et al.. (2021). Extrauterine Mesonephric-like Neoplasms. The American Journal of Surgical Pathology. 46(1). 124–133. 34 indexed citations

Kashem, Mohammed A., Chunling Wa, John P. Wolak, et al.. (2014). A High-Throughput Scintillation Proximity Assay for Sphingosine-1-Phosphate Lyase. Assay and Drug Development Technologies. 12(5). 293–302. 11 indexed citations

Lewis, Nuruddeen D., Lori Patnaude, Josephine Pelletier, et al.. (2014). A GPBAR1 (TGR5) Small Molecule Agonist Shows Specific Inhibitory Effects on Myeloid Cell Activation In Vitro and Reduces Experimental Autoimmune Encephalitis (EAE) In Vivo. PLoS ONE. 9(6). e100883–e100883. 54 indexed citations

10.

Lewis, Nuruddeen D., Sokol Haxhinasto, Shawn Anderson, et al.. (2013). Circulating Monocytes Are Reduced by Sphingosine-1-Phosphate Receptor Modulators Independently of S1P3. The Journal of Immunology. 190(7). 3533–3540. 54 indexed citations

11.

Giblin, Patricia, Rainer Boxhammer, Sudha Desai, et al.. (2011). Fully human antibodies against the Protease-Activated Receptor-2 (PAR-2) with anti-inflammatory activity. Human Antibodies. 20(3-4). 83–94. 9 indexed citations

12.

Desai, Sudha, Della White, Kathryn O’Shea, et al.. (2006). An orally active reversible inhibitor of cathepsin S inhibits human trans vivo delayed-type hypersensitivity. European Journal of Pharmacology. 538(1-3). 168–174. 6 indexed citations

13.

Panzenbeck, M. J., Deborah D. Jeanfavre, Terence A. Kelly, et al.. (2006). An orally active, primate selective antagonist of LFA-1 inhibits delayed-type hypersensitivity in a humanized-mouse model. European Journal of Pharmacology. 534(1-3). 233–240. 8 indexed citations

14.

Winquist, Raymond J., Sudha Desai, Nancy Haynes, et al.. (2001). The role of leukocyte function-associated antigen-1 in animal models of inflammation. European Journal of Pharmacology. 429(1-3). 297–302. 9 indexed citations

15.

Desai, Sudha, Steven Kerr, M. J. Panzenbeck, et al.. (1996). Effects of the renin inhibitor, BILA 2157 BS, on PRA and plasma AII in conscious non-human primates. The FASEB Journal. 10(3). 698. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact